B. Riley Wealth Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$799K Buy
8,643
+240
+3% +$21K 0.04% 356
2026
Q1
$720K Sell
8,403
-784
-9% -$69.9K 0.05% 359
2025
Q4
$726K Sell
9,187
-827
-8% -$64.8K 0.03% 412
2025
Q3
$801K Sell
10,014
-1,513
-13% -$129K 0.04% 391
2025
Q2
$1.05M Buy
+11,527
New +$1.05M 0.05% 345
2024
Q4
$1.29M Sell
14,209
-1,653
-10% -$158K 0.04% 376
2024
Q3
$1.63M Sell
15,862
-1,989
-11% -$203K 0.05% 369
2024
Q2
$1.73M Buy
17,851
+1,212
+7% +$112K 0.04% 379
2024
Q1
$1.18M Buy
16,639
+138
+0.8% +$11.7K 0.03% 476
2023
Q4
$1.32M Sell
16,501
-138
-0.8% -$10.4K 0.04% 455
2023
Q3
$1.18M Sell
16,639
-44,889
-73% -$3.36M 0.03% 476
2023
Q2
$4.74M Buy
61,528
+39,726
+182% +$3.08M 0.11% 195
2023
Q1
$1.64M Buy
21,802
+4,346
+25% +$323K 0.04% 400
2022
Q4
$1.38M Sell
17,456
-205
-1% -$15.4K 0.04% 443
2022
Q3
$1.24M Buy
17,661
+3,301
+23% +$259K 0.04% 441
2022
Q2
$1.15M Buy
14,360
+218
+2% +$17K 0.05% 377
2022
Q1
$1.07M Sell
14,142
-1,115
-7% -$88.3K 0.04% 464
2021
Q4
$1.3M Sell
15,257
-247
-2% -$19.3K 0.04% 450
2021
Q3
$1.18M Sell
15,504
-393
-2% -$31.2K 0.04% 469
2021
Q2
$1.29M Buy
15,897
+492
+3% +$40.2K 0.04% 441
2021
Q1
$1.22M Buy
15,405
+3,432
+29% +$269K 0.04% 429
2020
Q4
$1.02M Sell
11,973
-463
-4% -$38.3K 0.05% 319
2020
Q3
$955K Buy
12,436
+3,666
+42% +$280K 0.05% 318
2020
Q2
$643K Sell
8,770
-420
-5% -$29.8K 0.04% 376
2020
Q1
$611K Sell
9,190
-14,129
-61% -$996K 0.05% 340
2019
Q4
$1.61M Buy
23,319
+13,632
+141% +$929K 0.14% 168
2019
Q3
$713K Buy
9,687
+1,248
+15% +$90.5K 0.07% 293
2019
Q2
$605K Buy
8,439
+1
+0% +$71 0.07% 305
2019
Q1
$579K Buy
8,438
+242
+3% +$15.6K 0.07% 291
2018
Q4
$488K Sell
8,196
-53
-0.6% -$3.32K 0.07% 304
2018
Q3
$553K Sell
8,249
-117
-1% -$7.79K 0.07% 323
2018
Q2
$543K Buy
8,366
+559
+7% +$36.6K 0.07% 302
2018
Q1
$561K Sell
7,807
-543
-7% -$39.1K 0.08% 277
2017
Q4
$631K Sell
8,350
-233
-3% -$17K 0.09% 258
2017
Q3
$626K Sell
8,583
-344
-4% -$24.8K 0.1% 215
2017
Q2
$663K Buy
8,927
+311
+4% +$23.1K 0.12% 206
2017
Q1
$632K Buy
8,616
+1,497
+21% +$105K 0.13% 201
2016
Q4
$466K Buy
7,119
+993
+16% +$68.1K 0.09% 244
2016
Q3
$455K Buy
6,126
+44
+0.7% +$3.25K 0.09% 288
2016
Q2
$446K Sell
6,082
-7
-0.1% -$498 0.09% 278
2016
Q1
$430K Buy
6,089
+1,208
+25% +$80.4K 0.1% 251
2015
Q4
$326K Buy
+4,881
New +$325K 0.07% 343
2015
Q1
Sell
-1,812
Closed -$125 805
2014
Q4
$125 Buy
+1,812
New +$122K ﹤0.01% 1598
2014
Q3
Sell
-3,208
Closed -$219K 851
2014
Q2
$219K Buy
3,208
+694
+28% +$46.5K 0.05% 419
2014
Q1
$163K Sell
2,514
-252
-9% -$15.9K 0.05% 452
2013
Q4
$180K Buy
2,766
+1
+0% +$64 0.06% 378
2013
Q3
$164K Sell
2,765
-306
-10% -$18.1K 0.06% 399
2013
Q2
$176K Buy
+3,071
New +$182K 0.06% 379

Other funds holding CL

B. Riley Wealth Advisors's CL Position: Q2 2026 in Review

B. Riley Wealth Advisors increased its Colgate-Palmolive (CL) stake by 2.9% in Q2 2026, buying an estimated $21K and bringing the position to 8,643 shares worth $799K. The position accounts for 0.04% of the portfolio, ranked #356.

B. Riley Wealth Advisors first reported a position in CL in Q2 2013 and has held it in 48 quarters since. The position peaked at $4.74M in Q2 2023. 606 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • B. Riley Wealth Advisors held 8,643 shares of Colgate-Palmolive worth $799K as of Q2 2026.
  • B. Riley Wealth Advisors bought 240 Colgate-Palmolive shares in Q2 2026, an estimated $21K.
  • Colgate-Palmolive made up 0.04% of B. Riley Wealth Advisors's portfolio in Q2 2026, its #356 holding.
  • B. Riley Wealth Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 48 quarters since.
  • B. Riley Wealth Advisors's Colgate-Palmolive position peaked at $4.74M in Q2 2023.
  • 606 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.